miRNA-132 induces hepatic steatosis and hyperlipidaemia by synergistic multitarget suppression.
Hanin G, Yayon N, Tzur Y, Haviv R, Bennett ER, Udi S, Krishnamoorthy YR, Kotsiliti E, Zangen R, Efron B, Tam J, Pappo O, Shteyer E, Pikarsky E, Heikenwalder M, Greenberg DS, Soreq H.
Hanin G, et al.
Gut. 2018 Jun;67(6):1124-1134. doi: 10.1136/gutjnl-2016-312869. Epub 2017 Apr 5.
Gut. 2018.
PMID: 28381526
Free PMC article.